Abstract
Objectives: To assess the motivation of cancer survivors to consume medical cannabis and to assess the patterns of use, perceived efficacy, as well as side and adverse effects.
Methods: Cross-sectional survey among 190 Israeli cancer survivors who were licensed to use medical cannabis in a single institution. In addition to demographic information, the questionnaire examined patterns of use (including dosage, type of cannabis and way of administration), motivation for medical cannabis consumption, perceived efficacy, adverse and side effects, motivation for ceasing cannabis consumption, and tobacco smoking.
Results: The mean monthly dosage of cannabis consumed was 42.4 grams; 95.8% of respondents reported not consuming cannabis regularly before being diagnosed with cancer; the most common way of administration was smoking, and most of the participants reported taking cannabis throughout the day. The most common symptoms for which participants took medical cannabis were pain (n = 169, 88.9%), sleeping disorder (n = 144, 75.8%) and anxiety (n = 79, 41.6%). Twenty patients (10.5%) reported on mild side (or adverse) effects.
Conclusions: This study indicates that cancer survivors may indeed consume cannabis for symptom relief, and not merely for recreational purposes. Although our findings point to perceived safety and efficacy of medical cannabis for cancer survivors, more research is needed to study the adequate role that cannabis may have for treating symptoms associated with cancer survivorship.
Keywords: Cancer survivors, Medical cannabis, Medical marijuana, Symptom management
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
[CHARACTERISTICS OF MEDICAL CANNABIS USAGE AMONG PATIENTS WITH FIBROMYALGIA].Harefuah. 2020 May;159(5):343-348.PMID: 32431124 Hebrew.
-
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.Addiction. 2016 Jun;111(6):973-80. doi: 10.1111/add.13282. Epub 2016 Jan 26.PMID: 26687431 Free PMC article. Review.
-
Pain Relief as a Motivation for Cannabis Use Among Young Adult Users With and Without Chronic Pain.J Pain. 2019 Aug;20(8):908-916. doi: 10.1016/j.jpain.2019.02.001. Epub 2019 Feb 6.PMID: 30735731
-
Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients.Harm Reduct J. 2019 Jan 28;16(1):9. doi: 10.1186/s12954-019-0278-6.PMID: 30691503 Free PMC article.
-
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.Res Social Adm Pharm. 2016 Jul-Aug;12(4):638-54. doi: 10.1016/j.sapharm.2015.09.002. Epub 2015 Sep 16.PMID: 26443472 Review.